【24h】

Gelsolin decreases actin toxicity and inflammation in murine multiple sclerosis

机译:凝溶胶蛋白降低小鼠多发性硬化症的肌动蛋白毒性和炎症

获取原文
获取原文并翻译 | 示例
           

摘要

Gelsolin is the fourth most abundant protein in the body and its depletion in the blood has been found in multiple sclerosis (MS) patients. How gelsolin affects the MS brain has not been studied. We found that while the secreted form of gelsolin (pGSN) decreased in the blood of experimental autoimmune encephalomyelitis (EAE) mice, pGSN concentration increased in the EAE brain. Recombinant human pGSN (rhp-GSN) decreased extracellular actin and myeloperoxidase activity in the brain, resulting in reduced disease activity and less severe clinical disease, suggesting that gelsolin could be a potential therapeutic target for MS. (C) 2015 Elsevier B.V. All rights reserved.
机译:凝溶胶蛋白是人体中第四大最丰富的蛋白质,在多发性硬化症(MS)患者中已发现其在血液中的耗竭。凝溶胶蛋白如何影响MS大脑尚未研究。我们发现,虽然实验性自身免疫性脑脊髓炎(EAE)小鼠血液中凝溶胶蛋白(pGSN)的分泌形式减少,但EAE脑中pGSN浓度却增加了。重组人pGSN(rhp-GSN)降低了大脑中的细胞外肌动蛋白和髓过氧化物酶的活性,从而导致疾病活性降低和临床病情减轻,表明凝溶胶蛋白可能是MS的潜在治疗靶标。 (C)2015 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号